| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total revenue | 10,839,954 | 10,441,244 | 10,486,939 | 10,016,416 |
| Property taxes, insurance and other operating | 8,519,256 | 8,156,177 | 8,080,969 | 7,573,735 |
| Depreciation and amortization | - | - | - | 374,118 |
| General and administrative | 2,146,196 | 2,236,266 | 2,365,088 | 2,395,897 |
| Provision for credit losses | 106,763 | 136,348 | 99,608 | 844,429 |
| Depreciation | 364,699 | 362,742 | 363,020 | - |
| Total expenses | 11,136,914 | 10,891,533 | 10,908,685 | 11,188,179 |
| Loss from operations | -296,960 | -450,289 | -421,746 | -1,171,763 |
| Interest expense, net | 205,700 | 225,991 | 542,667 | - |
| Gain on sale of an asset | - | 0 | - | - |
| Income from employee retention credits | 659,923 | 326,500 | - | - |
| Other income | 595,102 | 41,753 | 308,444 | 39,771 |
| Interest expense, debt, excluding amortization | - | - | - | 471,356 |
| Amortization of debt discount | - | - | - | 3,774 |
| Total other income (expense) | 1,049,325 | 142,262 | -234,223 | -435,359 |
| Net income (loss) | 752,365 | -308,027 | -655,969 | -1,607,122 |
| Series d preferred dividends | 7,500 | 7,500 | 15,000 | 7,500 |
| Net income (loss) attributable to common stockholders | 744,865 | -315,527 | -670,969 | -1,614,622 |
| Net (loss) income per share attributable to common stockholders basic | 0.24 | -0.1 | -0.22 | -0.52 |
| Net (loss) income per share attributable to common stockholders diluted | 0.24 | -0.1 | -0.22 | -0.52 |
| Weighted average common shares outstanding basic | 3,067,059 | 3,067,059 | 3,067,059 | 3,067,059 |
| Weighted average common shares outstanding diluted | 3,067,059 | 3,067,059 | 3,067,059 | 3,067,059 |
SELECTIS HEALTH, INC. (GBCS)
SELECTIS HEALTH, INC. (GBCS)